Guardant Health, Inc. (NASDAQ:GH) Released Earnings Last Week And Analysts Lifted Their Price Target To US$59.17
Leerink Partners Maintains Guardant Health(GH.US) With Buy Rating, Announces Target Price $65
J.P. Morgan Maintains Guardant Health(GH.US) With Buy Rating, Raises Target Price to $60
A Quick Look at Today's Ratings for Guardant Health(GH.US), With a Forecast Between $50 to $70
Morgan Stanley Raises Price Target on Guardant Health to $60 From $52, Keeps Overweight Rating
Research Alert: CFRA Reiterates Buy View On Shares Of Guardant Health, Inc
Analysts Offer Insights on Healthcare Companies: Guardant Health (GH), Humana (HUM) and Evolus (EOLS)
Cathie Wood Pours $9.8 Million In Robinhood Despite Crypto Revenue Slump, Keeps Dumping Palantir Ahead Of Earnings
Guardant Health Reports Strong Q1 Revenue Growth
Cathie Wood's ARK Investment Buys 186.8K Shares of Guardant Health Today
Express News | Form 144 | Guardant Health(GH.US) Officer Proposes to Sell 16.66 Million in Common Stocks
Stifel Maintains Buy on Guardant Health, Raises Price Target to $60
Express News | Barclays Maintains Overweight on Guardant Health, Raises Price Target to $60
Guardant Health Is Maintained at Buy by TD Securities
Guardant Health Price Target Raised to $60.00/Share From $56.00 by TD Securities
10 Stocks Defying Wall Street Turbulence to Kick off the Month of May
Express News | UBS Maintains Buy on Guardant Health, Raises Price Target to $70
Guardant Health Analyst Ratings
Exchange-Traded Funds, Equity Futures Rise Pre-Bell Thursday; Tech Earnings Regain Investors' Confidence
S&P 500 Futures Rise In Premarket Trading; McCormick Vtg, Glaukos Lag